Astrazeneca Plc: (NYSE: AZN)
$51.56
-0.27 (-0.52%)
Volume 2,727,054
May 17 04:00 PM ET
Zacks Rank: 3-Hold 
| #3 |
Overview Quote
Stock Activity
| Day Low - High | 51.33 - 51.69 |
| 52wk Low - High | 39.72 - 52.27 |
| Previous Close | 51.83 |
| Avg. Volume | 1,551,339 |
| Industry | LARGE CAP PHARMA |
| Market Cap | 64.30 B |
| Div - Yield | 2.80 - 5.43 |
| Beta | 0.61 |
| PE (Forward) | 9.73 |
| Current Year Est. | 5.30 |
| Quarterly Earnings ESP |
0.00% |
Premium research
Zacks Rank
|
3 |
Zacks Recommendation
|
Neutral |
Zacks Industry Rank
|
170 out of 265 |
Equity Research Report
|
PREMIUM |
( = Change in last 30 days)
Get all our stock ratings and recommendations with a Free Trial to Zacks Premium Start Free Trial
Key Earnings Data
| PE (Forward) | 9.73 |
| PEG Ratio | -1.91 |
| Current Year Est. | 5.30 |
| Current Quarter Estimate | 1.27 |
| Most Accurate Estimate | 1.27 |
| Earnings ESP |
0.00% |
| Next Earnings Report Date | 07-25-2013 |
| EPS Last Year | 6.17 |
| Expected Earnings Growth | -5.10% |
Company Description
AstraZeneca PLC is one of the top five pharmaceutical companies in the world based on sales and is a therapeutic leader in cardiovascular, gastrointestinal, oncology, anesthesia including pain management, central nervous system (CNS) and respiratory products. They are engaged in the research, development, manufacture and marketing of ethical (prescription) pharmaceuticals and agricultural products, and the supply of healthcare services.
NYSE data is at least 20 minutes delayed.
NASDAQ data is at least 15 minutes delayed.
Turn Earnings Surprises into quick profits.
Earnings Estimates
| Current Qtr (06/2013) |
Next Qtr (09/2013) |
Current Year (12/2013) |
Next Year (12/2014) |
|
|---|---|---|---|---|
| Average Estimate | 1.27 | 1.38 | 5.30 | 5.06 |
| Number of Estimates | 2 | 2 | 6 | 5 |
| Low Estimate | 1.26 | 1.36 | 5.06 | 4.55 |
| High Estimate | 1.28 | 1.39 | 5.46 | NA |
| Year Ago EPS | 1.53 | 1.51 | 6.86 | 5.30 |
| EPS Growth | -16.99% | -8.94% | -22.74% | -4.53% |
Industry Analysis
| Name | Symbol | Previous Close | Zacks Rank | Zacks Recommendation |
|---|---|---|---|---|
| ASTRAZENECA PLC | AZN | 51.56 | |
|
| ABBOTT LABS | ABT | 36.59 | |
|
| ABBVIE INC | ABBV | 47.17 | |
|
| ALLERGAN INC | AGN | 101.41 | |
|
| BAYER A G -ADR | BAYRY | 108.13 | |
|
| BRISTOL-MYERS | BMY | 43.30 | |
|
| GLAXOSMITHKLINE | GSK | 52.22 | |
|
| JOHNSON & JOHNS | JNJ | 88.09 | |
|
| LILLY ELI & CO | LLY | 55.90 | |
|
| MERCK & CO INC | MRK | 45.99 | |
|
Sector:Medical>> Industry:LARGE CAP PHARMA
COMPARE TICKER vs. Its Peers
Zacks Commentary
Good News for Roche's Tarceva
May 16, 2013
Wider-than-Expected Loss at Optimer
May 10, 2013
Narrower-Than-Expected Loss at Rigel Pharma
May 09, 2013
Will DENTSPLY Beat Earnings in 1Q?
May 08, 2013
Isis Initiates ISIS-STAT3 Study
May 07, 2013
Wider-than-Expected Loss at Dynavax
May 07, 2013
AstraZeneca Earnings Tumble Y/Y
Apr 26, 2013
Loss Widens at Ironwood
Apr 24, 2013
Financials
| EPS TTM | 6.17 |
| Sales | 27,973 |
| Net Income | 5,668 |
| Price/Earnings | 8.36 |
| Price/Book | 2.86 |
| Price/Cash Flow | 5.75 |
| Price/Sales | 2.38 |
News
1 Giant Leap for MannKind - TheMotleyFool
May 18, 2013
Pick Your Poison: Overweight or High Cholesterol - TheMotleyFool
May 18, 2013
U.S. Steel, Genomic Health and Other Stocks Insiders Are Buying - Benzinga
May 18, 2013
Analyzing the Chemical Industry in the UK 2013 - M2
May 17, 2013
Volume Spike Detected in Shares of AstraZeneca as They Move Lower on 1.3x Above-Average Volume (AZN) - Financial News Network Online - Unusual Volume
May 17, 2013
Cheerleaders: Look Beyond Pharma For Jobs - YCharts
May 16, 2013
Benzinga`s M&A Chatter for Wednesday May 15, 2013 - Benzinga
May 15, 2013
Is AstraZeneca Gearing Up for a Shopping Spree? - TheMotleyFool
May 15, 2013
Broker Recommendations
| Current ABR | 3.13 |
| ABR (Last Week) | 3.13 |
| # of recs in ABR | 8 |
| Average Target Price | 50.02 |
| Industry Rank by ABR | 170 out of 265 |
| Rank in Industry | 1 out of 15 |
